← Back to Search

Proton Beam Therapy

Proton Beam Therapy for Chondrosarcoma

Phase 2
Waitlist Available
Led By David Grosshans, MD,PHD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The patient has been assessed by MDACC skull base surgeons to have undergone maximal surgical debulking of disease
Karnofsky Performance status greater than or equal to 60
Must not have
Previous irradiation of the skull base
Documented evidence of disseminated metastatic disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to local recurrence (evaluation every six months during estimated 5 year study)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether proton beam therapy, with or without photon beam radiation, is effective in treating skull base chondrosarcoma. The safety of this treatment will also be studied.

Who is the study for?
This trial is for individuals with a type of bone cancer called chondrosarcoma located at the base of the skull. Participants should have had most of their tumor surgically removed, be able to perform daily activities with minimal assistance (Karnofsky Performance status ≥60), and must provide signed consent. They cannot join if they have cancer spread throughout the body or previous radiation treatment to the skull base.
What is being tested?
The study is examining how effective proton beam therapy is on its own or combined with photon beam radiation in treating skull base chondrosarcoma. Researchers want to see how well these therapies work and monitor their safety for patients.
What are the potential side effects?
Potential side effects from proton beam therapy may include skin redness, soreness, fatigue, hair loss at the treatment site, headaches, and nausea. The exact side effects can vary based on individual patient factors.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I've had surgery to remove as much of my skull base tumor as possible.
Select...
I can care for myself but may not be able to do active work.
Select...
My cancer is a Grade 1-3 chondrosarcoma located at the base of my skull.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had radiation treatment on the base of my skull.
Select...
My cancer has spread to other parts of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to local recurrence (evaluation every six months during estimated 5 year study)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to local recurrence (evaluation every six months during estimated 5 year study) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Time to Local Recurrence

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Proton Beam TherapyExperimental Treatment1 Intervention
Proton Beam Therapy - A total dose of up to 70 CGE given at 2.0 CGE per daily fraction for 35 fractions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Proton Beam Therapy
2012
N/A
~160

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,062 Previous Clinical Trials
1,800,736 Total Patients Enrolled
3 Trials studying Chondrosarcoma
148 Patients Enrolled for Chondrosarcoma
David Grosshans, MD,PHDPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Proton Beam Therapy (Proton Beam Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT00496522 — Phase 2
Chondrosarcoma Research Study Groups: Proton Beam Therapy
Chondrosarcoma Clinical Trial 2023: Proton Beam Therapy Highlights & Side Effects. Trial Name: NCT00496522 — Phase 2
Proton Beam Therapy (Proton Beam Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00496522 — Phase 2
~1 spots leftby Aug 2026